Effects of Spirulina consumption on patients with hypertensio
Phase 3
- Conditions
- Primary Hypertension.Essential (primary) hypertension
- Registration Number
- IRCT20200404046940N1
- Lead Sponsor
- Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 48
Inclusion Criteria
Systolic blood pressure 130 mm Hg or more
Diastolic blood pressure 80 mm Hg or more
Both of the above
Between the age of 24 and 65 years
Exclusion Criteria
Suffering from cardiovascular, liver, kidney, inflammatory bowel disease, diabetes and thyroid disorders
History of cardiac surgery
Weight loss of more than 5% in the last 3 months
Participate in other studies in the last 6 months
Use any supplements or diets
Pregnancy and lactation
History of inflammation in the past two weeks (including infection, fracture, etc.)
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Blood pressure. Timepoint: Measurement of blood pressure before and 60 days after the intervention. Method of measurement: Digital Arm Sphygmomanometer.;Serum lipid profile. Timepoint: Before and 60 days after the intervention. Method of measurement: By the means of Pars Azmoon Company kit and auto analyzer BT 1500.;Hs-CRP (high-sensitivity C-reactive protein). Timepoint: Before and 60 days after the intervention. Method of measurement: By Enzyme-linked immunosorbent assay (ELISA) kit.;Malondialdehyde. Timepoint: Before and 60 days after the intervention. Method of measurement: Thiobarbituric acid method.
- Secondary Outcome Measures
Name Time Method